Annual SGA
$117.53 M
+$25.50 M+27.71%
December 31, 2023
Summary
- As of February 8, 2025, RYTM annual SGA is $117.53 million, with the most recent change of +$25.50 million (+27.71%) on December 31, 2023.
- During the last 3 years, RYTM annual SGA has risen by +$71.41 million (+154.81%).
- RYTM annual SGA is now at all-time high.
Performance
RYTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$35.38 M
-$1.04 M-2.85%
September 30, 2024
Summary
- As of February 8, 2025, RYTM quarterly SGA is $35.38 million, with the most recent change of -$1.04 million (-2.85%) on September 30, 2024.
- Over the past year, RYTM quarterly SGA has increased by +$995.00 thousand (+2.89%).
- RYTM quarterly SGA is now -2.85% below its all-time high of $36.41 million, reached on June 30, 2024.
Performance
RYTM Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$4.11 B
-$258.91 M-6.72%
September 30, 2024
Summary
- As of February 8, 2025, RYTM TTM SGA is -$4.11 billion, with the most recent change of -$258.91 million (-6.72%) on September 30, 2024.
- Over the past year, RYTM TTM SGA has dropped by -$4.24 billion (-3330.14%).
- RYTM TTM SGA is now -5271.13% below its all-time high of -$76.54 million.
Performance
RYTM TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RYTM Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.7% | +2.9% | -3330.1% |
| 3 y3 years | +154.8% | +68.5% | -6103.0% |
| 5 y5 years | +318.6% | +68.5% | -6103.0% |
RYTM Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.6% | -2.9% | +68.5% | -118.5% | at low |
| 5 y | 5-year | at high | +221.6% | -2.9% | +296.6% | -278.0% | at low |
| alltime | all time | at high | +3331.6% | -2.9% | +3502.6% | -5271.1% | at low |
Rhythm Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $35.38 M(-2.9%) | $138.55 M(+3.7%) |
| Jun 2024 | - | $36.41 M(+5.9%) | $133.65 M(+5.0%) |
| Mar 2024 | - | $34.38 M(+6.2%) | $127.28 M(+8.3%) |
| Dec 2023 | $117.53 M(+27.7%) | $32.37 M(+6.2%) | $117.53 M(+5.4%) |
| Sep 2023 | - | $30.48 M(+1.4%) | $111.47 M(+8.3%) |
| Jun 2023 | - | $30.05 M(+22.0%) | $102.94 M(+8.1%) |
| Mar 2023 | - | $24.63 M(-6.4%) | $95.22 M(+3.5%) |
| Dec 2022 | $92.03 M(+34.4%) | $26.32 M(+20.0%) | $92.03 M(+6.1%) |
| Sep 2022 | - | $21.94 M(-1.7%) | $86.71 M(+5.4%) |
| Jun 2022 | - | $22.33 M(+4.1%) | $82.28 M(+9.1%) |
| Mar 2022 | - | $21.45 M(+2.2%) | $75.42 M(+10.1%) |
| Dec 2021 | $68.49 M(+48.5%) | $21.00 M(+19.9%) | $68.49 M(+13.0%) |
| Sep 2021 | - | $17.51 M(+13.2%) | $60.61 M(+11.4%) |
| Jun 2021 | - | $15.46 M(+6.5%) | $54.39 M(+13.7%) |
| Mar 2021 | - | $14.52 M(+10.7%) | $47.85 M(+3.7%) |
| Dec 2020 | $46.13 M | $13.12 M(+16.2%) | $46.13 M(+8.7%) |
| Sep 2020 | - | $11.29 M(+26.5%) | $42.42 M(+1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $8.92 M(-30.3%) | $41.67 M(+0.2%) |
| Mar 2020 | - | $12.80 M(+35.9%) | $41.59 M(+13.8%) |
| Dec 2019 | $36.55 M(+30.2%) | $9.41 M(-10.6%) | $36.55 M(+2.9%) |
| Sep 2019 | - | $10.54 M(+19.2%) | $35.52 M(+6.0%) |
| Jun 2019 | - | $8.84 M(+13.9%) | $33.53 M(+7.7%) |
| Mar 2019 | - | $7.76 M(-7.5%) | $31.12 M(+10.8%) |
| Dec 2018 | $28.08 M(+195.0%) | $8.39 M(-1.8%) | $28.08 M(+16.9%) |
| Sep 2018 | - | $8.54 M(+32.7%) | $24.02 M(+35.0%) |
| Jun 2018 | - | $6.44 M(+36.5%) | $17.80 M(+39.9%) |
| Mar 2018 | - | $4.71 M(+8.9%) | $12.72 M(+33.6%) |
| Dec 2017 | $9.52 M(+50.8%) | $4.33 M(+87.0%) | $9.52 M(+20.0%) |
| Sep 2017 | - | $2.31 M(+70.6%) | $7.93 M(+20.2%) |
| Jun 2017 | - | $1.36 M(-10.5%) | $6.60 M(+25.9%) |
| Mar 2017 | - | $1.52 M(-44.8%) | $5.24 M(+40.7%) |
| Dec 2016 | $6.31 M(+84.3%) | $2.74 M(+179.4%) | $3.73 M(+279.4%) |
| Sep 2016 | - | $982.00 K | $982.00 K |
| Dec 2015 | $3.42 M | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual SGA year-on-year change?
- What is Rhythm Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly SGA year-on-year change?
- What is Rhythm Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM SGA year-on-year change?
What is Rhythm Pharmaceuticals annual SGA?
The current annual SGA of RYTM is $117.53 M
What is the all time high annual SGA for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual SGA is $117.53 M
What is Rhythm Pharmaceuticals annual SGA year-on-year change?
Over the past year, RYTM annual SGA has changed by +$25.50 M (+27.71%)
What is Rhythm Pharmaceuticals quarterly SGA?
The current quarterly SGA of RYTM is $35.38 M
What is the all time high quarterly SGA for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly SGA is $36.41 M
What is Rhythm Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, RYTM quarterly SGA has changed by +$995.00 K (+2.89%)
What is Rhythm Pharmaceuticals TTM SGA?
The current TTM SGA of RYTM is -$4.11 B
What is the all time high TTM SGA for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM SGA is -$76.54 M
What is Rhythm Pharmaceuticals TTM SGA year-on-year change?
Over the past year, RYTM TTM SGA has changed by -$4.24 B (-3330.14%)